Fungemia in COVID‐19 ICU patients, a single medical center experience

A known proportion of patients who are admitted for the novel coronavirus disease 2019 (COVID-19) requires intensive care unit (ICU) level care. Prolonged ICU stay is a risk factor development nosocomial candidemia. The current study aimed to investigate incidence and factors associated with candidemia among COVID-19. Patients developed were identified, their clinical course was reported. 1:3 case control matching used identify non-candidemia served as controls. 89 COVID-19 during period. 8.9% (n = 8). Case-control identified 24 similar severity at time admission. Median first isolation yeast 26 days. Candidemia reported longer median than (40 vs. 10 days, p .004). In hospital death rates comparable in both groups (38% 54%, .548). mechanical ventilation support